Skip to main content

A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Ravulizumab in Complement-Inhibitor-Naive Adult Patients with Generalized Myasthenia Gravis

Clinical Trial Grant
Duke Scholars

Administered By

Neurology, Neuromuscular Disease

Awarded By

Alexion Pharmaceuticals, Inc.

Start Date

June 18, 2019

End Date

December 31, 2023
 

Administered By

Neurology, Neuromuscular Disease

Awarded By

Alexion Pharmaceuticals, Inc.

Start Date

June 18, 2019

End Date

December 31, 2023